Human Biome Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $15M

  • Investors
  • 3

Human Biome General Information

Description

Operator of a microbiome company intended to develop the world's first biosynthetic, donor-independent, autonomous, bio-mimicking microbiome biotherapeutics predicted and synthesized in a deep-tech approach. The company combines microbiome knowledge and breakthrough technologies in one unique approach that is able to generate a pipeline of Biotherapeutics (NGBs) as Live Biotherapeutics Products (LBPs), enabling the scientific community to better understand the role of these microorganisms in human health and the cure of the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 85 Działkowa Street
  • Hall B
  • Warsaw, 02-234
  • Poland
+48 728
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • 85 Działkowa Street
  • Hall B
  • Warsaw, 02-234
  • Poland
+48 728

Human Biome Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Human Biome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 06-Aug-2024 $15M Completed Pre-Clinical Trials
2. Seed Round 31-Dec-2023 Completed Pre-Clinical Trials
1. Seed Round 06-Dec-2019 $129K $129K Completed Startup
To view Human Biome’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Human Biome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a microbiome company intended to develop the world's first biosynthetic, donor-independent, autonomous, bio-
Drug Discovery
Warsaw, Poland
30 As of 2026

Adelaide, Australia
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Human Biome Competitors (5)

One of Human Biome’s 5 competitors is BiomeBank, a Venture Capital-Backed company based in Adelaide, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BiomeBank Venture Capital-Backed Adelaide, Australia
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Microbiotica Venture Capital-Backed Cambridge, United Kingdom
MaaT Pharma Formerly VC-backed Lyon, France
Seres Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 5 competitors. Get the full list »

Human Biome Patents

Human Biome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025093779-A1 A platform for biotherapeutic drug discovery and a method for biotherapeutic drug discovery Inactive 05-Nov-2023
AU-2024370585-A1 Functional compositions and methods of use thereof in eradication and/or decolonization of antibiotic-resistant bacteria and restoration of healthy microbiota Pending 05-Nov-2023
EP-4801525-A1 Functional compositions and methods of use thereof in eradication and/or decolonization of antibiotic-resistant bacteria and restoration of healthy microbiota Pending 05-Nov-2023
WO-2025093778-A1 Functional compositions and methods of use thereof in eradication and/or decolonization of antibiotic-resistant bacteria and restoration of healthy microbiota Inactive 05-Nov-2023
AU-2024373322-A1 Functional compositions and methods of use thereof in the treatment and recurrence prophylaxis of clostridioides difficile infection and restoration of healthy microbiota Pending 05-Nov-2023 A61K35/741
To view Human Biome’s complete patent history, request access »

Human Biome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Human Biome Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
NCBR Investment Fund Venture Capital Minority
Solinea. Corporation Minority
Twiti Investments Venture Capital Minority
To view Human Biome’s complete investors history, request access »

Human Biome FAQs

  • When was Human Biome founded?

    Human Biome was founded in 2019.

  • Where is Human Biome headquartered?

    Human Biome is headquartered in Warsaw, Poland.

  • What is the size of Human Biome?

    Human Biome has 30 total employees.

  • What industry is Human Biome in?

    Human Biome’s primary industry is Drug Discovery.

  • Is Human Biome a private or public company?

    Human Biome is a Private company.

  • What is Human Biome’s current revenue?

    The current revenue for Human Biome is .

  • How much funding has Human Biome raised over time?

    Human Biome has raised $16.1M.

  • Who are Human Biome’s investors?

    NCBR Investment Fund, Solinea., and Twiti Investments have invested in Human Biome.

  • Who are Human Biome’s competitors?

    BiomeBank, Vedanta Biosciences, Microbiotica, MaaT Pharma, and Seres Therapeutics are competitors of Human Biome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process